The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53
Citations Over TimeTop 10% of 2016 papers
Abstract
As a deubiquitinating enzyme (DUB), the physiological substrates of ataxin-3 (ATX-3) remain elusive, which limits our understanding of its normal cellular function and that of pathogenic mechanism of spinocerebellar ataxia type 3 (SCA3). Here, we identify p53 to be a novel substrate of ATX-3. ATX-3 binds to native and polyubiquitinated p53 and deubiquitinates and stabilizes p53 by repressing its degradation through the ubiquitin (Ub)-proteasome pathway. ATX-3 deletion destabilizes p53, resulting in deficiency of p53 activity and functions, whereas ectopic expression of ATX-3 induces selective transcription/expression of p53 target genes and promotes p53-dependent apoptosis in both mammalian cells and the central nervous system of zebrafish. Furthermore, the polyglutamine (polyQ)-expanded ATX-3 retains enhanced interaction and deubiquitination catalytic activity to p53 and causes more severe p53-dependent neurodegeneration in zebrafish brains and in the substantia nigra pars compacta (SNpc) or striatum of a transgenic SCA3 mouse model. Our findings identify a novel molecular link between ATX-3 and p53-mediated cell death and provide an explanation for the direct involvement of p53 in SCA3 disease pathogenesis.
Related Papers
- → Dominantly Inherited Ataxias: Lessons Learned from Machado-Joseph Disease/Spinocerebellar Ataxia Type 3(2007)106 cited
- → Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado‐Joseph disease(1995)99 cited
- → Cerebellar lncRNA Expression Profile Analysis of SCA3/MJD Mice(2018)5 cited
- → First report on spinocerebellar ataxia type 3 (Machado–Joseph disease) in Poland(2022)1 cited
- [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].(2008)